S
Sandeep Kumar Srivastava
Researcher at All India Institute of Medical Sciences
Publications - 15
Citations - 267
Sandeep Kumar Srivastava is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Antigen & Parkia javanica. The author has an hindex of 7, co-authored 15 publications receiving 198 citations. Previous affiliations of Sandeep Kumar Srivastava include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Regulatory T Cells Suppress T Cell Activation at the Pathologic Site of Human Visceral Leishmaniasis
Ambak Kumar Rai,Chandreshwar Prasad Thakur,Amar Singh,Tulika Seth,Sandeep Kumar Srivastava,Pushpendra Singh,Dipendra Kumar Mitra +6 more
TL;DR: The results suggest that IL-10 plays an important role in suppression of host immunity in human VL and possibly determines the efficacy of chemotherapy.
Journal ArticleDOI
Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics.
Sandhya R. Panch,Sandeep Kumar Srivastava,Nasha Elavia,Andrew McManus,Shutong Liu,Ping Jin,Steven L. Highfill,Xiaobai Li,Pradeep K. Dagur,James N. Kochenderfer,Terry J. Fry,Crystal L. Mackall,Daniel Lee,Nirali N. Shah,David F. Stroncek +14 more
TL;DR: Cryopreservation during CART manufacture is a viable strategy, based on standard product release parameters, and early apoptotic cell-surface markers were significantly elevated in cryo-thawed CARTs.
Journal ArticleDOI
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Andreas D. Kistler,Geetika Singh,Mehmet M. Altintas,Hao Yu,Isabel Fernandez,Changkyu Gu,Cory Wilson,Sandeep Kumar Srivastava,Alexander Dietrich,Katherina Walz,Dontscho Kerjaschki,Phillip Ruiz,Stuart E. Dryer,Sanja Sever,Amit K. Dinda,Christian Faul,Jochen Reiser +16 more
TL;DR: The data suggest a dual and context dependent role of TRPC6 in podocytes where acute activation protects from complement-mediated damage, but chronic overactivation leads to focal segmental glomerulosclerosis.
Journal ArticleDOI
Is Interleukin 10 (IL10) Expression in Breast Cancer a Marker of Poor Prognosis
Hemanga K. Bhattacharjee,Virinder Kumar Bansal,Bikash Nepal,Sandeep Kumar Srivastava,Amit K. Dinda,Mahesh C. Misra +5 more
TL;DR: Correlation of IL 10 expressing tumours with several established poor prognostic markers of breast cancer may indicate the possible association of IL10 expression with poor prognosis.
Journal ArticleDOI
Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.
C.K. Prashant,Madhusudan Bhat,Sandeep Kumar Srivastava,Ankit Saxena,Manoj Kumar,Amar Singh,Mohammed Samim,Farhan Jalees Ahmad,Amit K. Dinda +8 more
TL;DR: TT-loaded small PCL NPs were able to generate persistent and strong CMI and humoral responses against TT 2 months after single injection in mice without booster dose, and this biodegradable nanoadjuvant system may help to develop single-shot immunization for prolonged immunity without booster doses.